First-Line Chemotherapy With or Without Neuromuscular Electrical Stimulation in Treating Patients With Non-Small Cell Lung Cancer

NCT01097317 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

52

Enrollment

OTHER

Sponsor class

Conditions

Chemotherapeutic Agent Toxicity
Fatigue
Lung Cancer
Musculoskeletal Complications

Interventions

DRUG: carboplatin
DRUG: vinorelbine tartrate
OTHER: neuromuscular electrical stimulation
OTHER: physiologic testing
PROCEDURE: fatigue assessment and management
PROCEDURE: quality-of-life assessment

Sponsor

Wales Cancer Trials Unit